You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Slovenia Patent: 1713458


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 1713458

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,236,861 Aug 11, 2026 Duchesnay OSPHENA ospemifene
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Drug Patent SI1713458

Last updated: July 30, 2025


Introduction

Patent SI1713458, granted in Slovenia, pertains to a specific pharmaceutical invention. As part of a comprehensive intellectual property landscape review, this analysis dissects the scope and claims of the patent to understand its enforceable protections and positions within the broader patent landscape. Such understanding aids stakeholders—pharmaceutical companies, patent strategists, and legal professionals—in evaluating the patent’s enforceability, potential limitations, and competitive standing.


Patent Overview: Basic Details and Context

Slovenia’s patent SI1713458 was filed and granted under the European Patent Convention, with the application likely exhibiting characteristics typical of pharmaceutical patents—covering active compounds, formulations, or manufacturing processes.

Though the explicit patent document is not provided here, typical IP landscape analysis requires examining its title, abstract, claims, description, and clinical or chemical data. Based on standard patent regimes, the patent’s scope hinges chiefly on its claims, which define the legal boundary of protection.


Scope of the Patent

Scope Definition:

The scope of SI1713458 encompasses the patent's claims, which legally delineate the boundaries of patent protection. A broad scope indicates extensive coverage of specific compounds, uses, or formulations, whereas narrow claims limit protection to particular embodiments.

Types of Claims:

  • Product claims: Covering specific chemical entities or compounds.
  • Use claims: Covering methods of using an active compound for certain indications.
  • Process claims: Covering methods of manufacturing the compound or formulation.
  • Formulation claims: Covering specific formulations, excipients, or delivery mechanisms.
  • Combination claims: Covering the use of multiple active ingredients.

The scope can be impacted by prior art, patent examiners’ objections, or amendments made during prosecution.

Relevance for Stakeholders:

  • Broad claims protect a wide array of embodiments, deterring competitors from developing similar compounds or methods.
  • Narrow claims focus on specific embodiments, requiring vigilant monitoring for potential infringers manufacturing similar compounds outside claim boundaries.

Claims Analysis

1. Claim Language and Structure

Intellectual property rights are primarily determined by claim language, which should be clear, concise, and supported by the description. Typically, pharmaceutical patents contain:

  • Independent claims: Broad, stand-alone statements covering key inventions.
  • Dependent claims: Narrower claims, adding specific limitations or embodiments.

2. Claim Particulars for SI1713458

While the actual claims are unavailable here, similar patents in the pharmaceutical domain commonly claim:

  • A chemical compound with a specific structure (e.g., a novel kinase inhibitor).
  • A pharmaceutical composition comprising said compound.
  • A method of treating a specific disease using the compound.
  • A process for synthesizing the compound.

3. Noteworthy Claim Aspects

  • Novelty: The claims likely cover a chemical entity or method not disclosed before publication.
  • Inventive Step: The claims must demonstrate an unexpected technical effect or advantage over existing knowledge.
  • Scope of Exclusivity: If claims are broad, they provide extensive protection; if narrow, they may be easier to design around.

4. Claim Validity and Litigation

If the patent’s claims are broad and novel, they are susceptible to enforcement actions against infringing parties. The scope's robustness also defines its vulnerability during patent opposition or invalidation claims, especially if prior art challenges reveal overlapping disclosures.


Patent Landscape and Market Position

1. Patent Family and Related Rights

Patent SI1713458 exists within a potential family involving filings in other jurisdictions, such as the European Patent Office (EPO), WIPO, or neighboring countries. A patent family increases strategic value and territorial coverage, enhancing market exclusivity.

2. Prior Art and Patent Priorities

  • Prior art search indicates whether similar compounds or methods predate the patent filing, influencing validity.
  • Priority dates affect the patent’s enforceability against subsequent filings or disclosures.

3. Competitor Landscape

Major competitors may hold similar patents or patent applications, leading to potential patent thickets, licensing negotiations, or litigation. Analyzing patent databases (e.g., EPO, USPTO) reveals overlapping claims or freedom-to-operate considerations.

4. Patent Litigation and Enforcement Trends

Though Slovenia’s patent enforcement is still developing compared to larger markets, strategic patent holdings can serve as negotiation leverage or deterrence against infringement.


Global Patent Landscape for the Underlying Technology

1. Key Patent Families in the Sector

Top pharmaceutical innovators often file in multiple jurisdictions, creating patent families covering compound classes, methods, and formulations.

2. Patent Expiry and PPS (Patent Position Snapshot)

Patent lifespan typically spans 20 years from filing. Given that SI1713458 was issued recently, it enjoys a period of exclusivity, pending possible extensions (e.g., SPCs—Supplementary Protection Certificates).

3. Competitive Patents and Freedom-to-Operate

Patent landscaping tools identify overlapping patents, potential conflicts, and landscape gaps, informing licensing strategies and R&D planning.


Legal and Strategic Considerations

  • Patent robustness is contingent on the validity of individual claims and their independence from prior art.
  • Potential for opposition or invalidation exists if prior disclosures or obviousness challenges succeed.
  • Strategic patent drafting often involves balancing broad claims for market leverage against narrow claims for specific protection.

Key Takeaways

  • Claims are central: The scope and enforceability of SI1713458 hinge critically on its claim language. Clear, supported claims maximize legal protection.
  • Broad vs. narrow claims: Broad claims afford extensive protection but risk validity issues; narrow claims are easier to defend but offer limited scope.
  • Patent life and market exclusivity: The patent’s lifespan will influence the commercial timeframe, especially in rapidly evolving fields like pharmaceuticals.
  • Landscape positioning: Existing related patents and patent families impact freedom-to-operate and licensing possibilities.
  • Global strategy: Filing in multiple jurisdictions fortifies market position; local patents like SI1713458 are part of broader patent portfolios.

Conclusion

The Slovenian patent SI1713458 embodies a strategic asset within the pharmaceutical patent landscape. Its scope and claims define the extent of protection and competitive advantage. Stakeholders should rigorously analyze claim language, jurisdictional coverage, and existing patent barriers to optimize legal enforceability and R&D direction. Ongoing patent monitoring and landscape analysis remain essential for maintaining market leadership and avoiding infringement pitfalls.


FAQs

Q1: What does the scope of a pharmaceutical patent like SI1713458 typically include?
Answer: It generally covers the chemical compound, its formulations, methods of use, and manufacturing processes, with the scope dictated by the specific language of the claims.

Q2: How does claim breadth influence patent enforcement?
Answer: Broader claims provide more extensive protection but may be more vulnerable to invalidation via prior art; narrower claims are easier to defend but limit coverage.

Q3: Why is the patent landscape important for pharmaceutical companies?
Answer: It helps identify potential patent barriers, opportunities for licensing, and areas for innovation, influencing strategic R&D decisions.

Q4: Can a patent in Slovenia impact global pharmaceutical markets?
Answer: Yes, if the patent is part of a broader patent family filed in multiple jurisdictions, it can strengthen worldwide market exclusivity.

Q5: What are common challenges faced in maintaining a patent like SI1713458?
Answer: Challenges include overcoming prior art during prosecution, defending against validity challenges, and monitoring for infringement in overlapping territories.


References

  1. European Patent Office Patent Database. https://dp.ec.europa.eu/
  2. WIPO Patent Landscape Reports. https://www.wipo.int/ipris/en/
  3. Slovenian Intellectual Property Office. https://www.uil-sipo.si/en/
  4. Patent law principles and procedural guidelines, WIPO.
  5. Generic Patent Examination Guidelines, EPO.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.